About Quotient Sciences
Quotient Sciences is a company based in Nottingham (United Kingdom) founded in 1990 was acquired by Permira in July 2019.. The company has 369 employees as of December 31, 2022. Quotient Sciences has completed 3 acquisitions, including Arc Trinova, QS Pharma and SeaView Research. Quotient Sciences operates in a competitive market with competitors including Nephron Pharmaceuticals, Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm and Suanfarma, among others.
- Headquarter Nottingham, United Kingdom
- Employees 369 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Permira
& 1 more
-
Employee Count
369
as on Dec 31, 2022
-
Investments & Acquisitions
Arc Trinova
& 2 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Quotient Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Quotient Sciences
Quotient Sciences has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Permira and Bridgepoint Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in technology, consumer, healthcare, and service sectors.
|
Founded Year | Domain | Location | |
|
Middle-market businesses up to €1 billion are acquired pan-Europe.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Quotient Sciences
Quotient Sciences has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Arc Trinova, QS Pharma and SeaView Research. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Contract manufacturing, bioanalytical, and consulting services are provided.
|
2016 | ||||
|
Contract development and manufacturing for small molecule pharmaceuticals are offered.
|
2002 | ||||
|
Early stage CRO, also offering clinical pharmacology testing and laboratory services
|
1995 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Quotient Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Quotient Sciences Comparisons
Competitors of Quotient Sciences
Quotient Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nephron Pharmaceuticals, Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm and Suanfarma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| domain | founded_year | HQ Location |
Company specializing in development of Biosimilars
|
|
| domain | founded_year | HQ Location |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO and analytical services for peptide development are provided.
|
|
| domain | founded_year | HQ Location |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| domain | founded_year | HQ Location |
Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Quotient Sciences
Frequently Asked Questions about Quotient Sciences
When was Quotient Sciences founded?
Quotient Sciences was founded in 1990.
Where is Quotient Sciences located?
Quotient Sciences is headquartered in Nottingham, United Kingdom.
How many employees does Quotient Sciences have?
As of Dec 31, 2022, the latest employee count at Quotient Sciences is 369.
What does Quotient Sciences do?
Quotient Sciences was founded in 1990 and is headquartered in Nottingham, United Kingdom. Operations focus on the pharmaceutical sector, where APIs and various finished dosage formsincluding tablets, capsules, liquids, inhaled, topical, rectal, and parenteral productsare developed and manufactured. Services encompass formulation design, pre-formulation screening, first-in-human studies, solubility enhancement, modified release technologies, analytical support, process optimization, and clinical trial manufacturing.
Who are the top competitors of Quotient Sciences?
Quotient Sciences's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
How many acquisitions has Quotient Sciences made?
Quotient Sciences has made 3 acquisitions, including Arc Trinova, QS Pharma, and SeaView Research.
Who are Quotient Sciences's investors?
Quotient Sciences has 2 investors. Key investors include Permira, and Bridgepoint Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.